Top German Growth Companies With High Insider Ownership In July 2024

In This Article:

Amidst a backdrop of fluctuating European markets and rising unemployment in Germany, investors are increasingly focused on stability and growth potential. High insider ownership in growth companies often signals strong confidence from those who know the business best, making such stocks particularly noteworthy in the current economic climate.

Top 10 Growth Companies With High Insider Ownership In Germany

Name

Insider Ownership

Earnings Growth

pferdewetten.de (XTRA:EMH)

26.8%

75.4%

Deutsche Beteiligungs (XTRA:DBAN)

35.4%

31.6%

YOC (XTRA:YOC)

24.8%

21.8%

NAGA Group (XTRA:N4G)

14.1%

79.2%

Exasol (XTRA:EXL)

25.3%

105.4%

Alelion Energy Systems (DB:2FZ)

37.4%

106.6%

Stratec (XTRA:SBS)

30.9%

21.9%

elumeo (XTRA:ELB)

25.8%

99.1%

Your Family Entertainment (DB:RTV)

17.5%

116.8%

Friedrich Vorwerk Group (XTRA:VH2)

18%

30.4%

Click here to see the full list of 18 stocks from our Fast Growing German Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Redcare Pharmacy

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Redcare Pharmacy NV is an online pharmacy operating across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market capitalization of approximately €2.63 billion.

Operations: The company generates revenue primarily through its DACH segment, which brought in €1.62 billion, and its International segment, contributing €369.34 million.

Insider Ownership: 17.7%

Earnings Growth Forecast: 46.7% p.a.

Redcare Pharmacy, a growth-oriented company in Germany, is trading at 37.9% below its estimated fair value, signaling potential undervaluation. The company's revenue is expected to grow by 17% annually, outpacing the German market average of 5.2%. Although its revenue growth rate falls short of the high-growth benchmark of 20%, earnings are projected to surge by approximately 46.67% annually. Redcare is also on track to become profitable within three years, aligning with above-average market growth expectations. However, shareholders have experienced dilution over the past year and the stock has shown high volatility recently.

XTRA:RDC Ownership Breakdown as at Jul 2024
XTRA:RDC Ownership Breakdown as at Jul 2024

Stratec

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Stratec SE operates in Germany and internationally, designing and manufacturing automation and instrumentation solutions for in-vitro diagnostics and life sciences, with a market cap of approximately €568.90 million.


Waiting for permission
Allow microphone access to enable voice search

Try again.